[1] 唐玉珍,陈竹,王丽,等. 乙型肝炎相关慢加急性肝衰竭患者的免疫状态及其与预后的相关性. 中国肝脏病杂志:电 子版,2016,8: 69-73. [2] Krenkel O,Mossanen JC,Tacke F. Immune mechanisms in acetaminophen-induced acute liver failure. Hepatobil Surg Nutr,2014,3:331-343. [3] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会 肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南( 2012 年 版). 中华临床感染病杂志,2012,5:321-327. [4] 中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南( 2015 年更新版). 临床肝胆病杂志,2015, 31:1941-1960. [5] Wang FS,Zhang Z. Liver:How can acute-on-chronic liver failure be accurately identified? Nat Rev Gastroenterol Hepatol,2013,10:390-391. [6] Garg H,Sarin SK,Kumar M,et al. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology,2011, 53:774-780. [7] Wu Z,Han M,Chen T,et al.Acute liver failure: mechanisms of immune—mediated liver injury.Liver Int,2010,30:782-794. [8] Mao WL,Chen Y,Chen YM,et al.Changes of serum cytokine levels in patients with acute on chronic liver failure treated by plasma exchange.J Clin Gastroenterol,201l,45:551-555. [9] 罗光成,黄云丽,闫惠平,等.HBV相关慢加急性肝衰竭患者血清细胞因子水平与疾病预后的关系研究.检验医学,2014,29:26-30. [10] Liu GW,Tang KC,Li Q,et al. Changes of IL-1,TNF-Alpha,IL-12 and IL-10 levels with chronic liver failure. Surg Sci,2011,2:69-72. |